# Gene therapy for sickle cell and β-thalassemia works by disrupting three-dimensional genome structure

**Category:** Health
**Source:** [https://www.stjude.org/media-resources/news-releases/2025-medicine-science-news.html](https://www.stjude.org/media-resources/news-releases/2025-medicine-science-news.html)
**Publisher:** St. Jude Children's Research Hospital
**Published:** 11/10/2025
**Scraped (UTC):** 2025-12-24T03:53:30+00:00

![Article Image](https://www.stjude.org/_jcr_content/image.img.800.high.jpg/1762275697689.jpg)

## Summary
Scientists identified a previously unknown treatment opportunity for sickle cell disease and β-thalassemia based on how CRISPR-based gene therapy works.

## Full Article
*(Article text could not be extracted. Visit source link above.)*

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*